atovaquone has been researched along with Malaria, Falciparum in 225 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 26 (11.56) | 18.2507 |
2000's | 95 (42.22) | 29.6817 |
2010's | 76 (33.78) | 24.3611 |
2020's | 28 (12.44) | 2.80 |
Authors | Studies |
---|---|
Baniecki, ML; Clardy, J; Wirth, DF | 1 |
Bertaux, L; Bogreau, H; Bouchiba, H; Garnotel, E; Kraemer, P; Parzy, D; Pradines, B; Rogier, C; Savini, H; Simon, F | 1 |
Ane, M; Baziard-Mouysset, G; El Hage, S; Marjorie, M; Payard, M; Stigliani, JL; Vial, H | 1 |
Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M | 1 |
Clark, JA; Connelly, MC; El Mazouni, F; Furimsky, A; Gow, J; Guiguemde, WA; Guy, RK; Iyer, L; Kyle, DE; Min, J; Mirsalis, J; Parman, T; Phillips, MA; Pradhan, A; Zhang, Y; Zhu, F | 1 |
Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
da Rocha, DR; Ferreira, VF; Garcia, CR; Gaur, P; Santos, IO; Sharma, A | 1 |
Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
Angulo-Barturen, I; Avery, VM; Awasthy, D; Balasubramanian, V; Bandodkar, B; Barde, SP; Bharath, S; Chinnapattu, M; Duffy, S; Ferrer, S; Gamo, FJ; Hameed P, S; Hosagrahara, V; Iyer, PS; Jatheendranath, S; Jiménez-Díaz, MB; Kavanagh, S; Koushik, K; Lukens, AK; Magistrado, PA; Manjrekar, P; Martínez, MS; Morayya, S; Mukherjee, K; Narayan, C; Narayanan, S; Panduga, V; Patil, V; Prabhakar, KR; Raichurkar, A; Ramachandran, S; Rautela, N; Reddy, J; Rudrapatna, SS; Sambandamurthy, VK; Sanz, LM; Saralaya, R; Shanbag, G; Sinha, A; Srivastava, A; Viswanath, P; Waterson, D; Wirth, DF | 1 |
Iyer, PS; Kannan, M; Khan, FR; Raichurkar, AV | 1 |
Bu, W; Campo, B; Ding, J; Easom, EE; Freund, YR; Gamo, FJ; Ge, M; Guo, D; Jacobs, RT; Li, L; Plattner, JJ; Rosenthal, PJ; Sanders, V; Sanz, LM; Yang, Y; Zhang, YK | 1 |
Angulo-Barturen, Í; Bahamontes-Rosa, N; Ballell-Pages, L; Berry, NG; Biagini, GA; Blackman, MJ; Calderón, F; Castañeda, P; Crespo, B; de Cózar, C; de Mercado, J; Fernández, J; Frigerio, M; Guijarro, L; Jiménez-Díaz, MB; Martínez-Martínez, MS; McConville, M; Nixon, GL; O'Neill, PM; Santos-Villarejo, Á; Sanz, LM; Ward, SA; Washbourn, G | 1 |
Berry, P; Campo, B; Cao, J; Ciaravino, V; Easom, EE; Erve, JCL; Freund, YR; Gamo, FJ; Guo, D; Jacobs, RT; Plattner, JJ; Rosenthal, PJ; Sanz, LM; Zhang, YK | 1 |
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA | 1 |
Boonhok, R; Chakrabarti, D; Huang, G; Melendez, J; Miao, J; Min, H; Solano, CM; Yu-Alfonzo, S; Yuan, Y | 1 |
Beteck, RM; Legoabe, LJ; Patel, OPS | 1 |
Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M | 1 |
Akao, Y; Avery, VM; Charman, SA; Chen, G; Chen, X; Chiu, FCK; Cho, N; Crespo, B; Dechering, KJ; Duffy, S; Kamaura, M; Katneni, K; Laleu, B; Lucantoni, L; Ochida, A; Sanz, LM; Shackleford, DM; Sturm, A; Wang, B; White, KL; Wittlin, S | 1 |
Ashton, M; Bergqvist, Y; Björkman, A; Gil, JP; Thapar, MM; Ursing, J | 1 |
Adams, KL; Bopp, S; Catteruccia, F; Dabiré, RK; Diabaté, A; Hien, DFS; Lefèvre, T; Ma, E; Paré, PSL; Paton, DG; Probst, AS; Shaw, WR; Singh, N; Volkman, SK; Wirth, DF; Yerbanga, RS | 1 |
Ahiya, AI; Lamb, IM; Lindner, SE; Mather, MW; Mell, JC; Morrisey, J; Rios, KT; Shukla, A; Vaidya, AB | 1 |
Dass, S; Ke, H; Ling, L; Mather, MW; Morrisey, JM; Vaidya, AB | 1 |
Ji, J; Sundquist, J; Sundquist, K; Zhang, N | 1 |
Alruwaili, M; Elahi, R; Prigge, S; Shapiro, T; Sullivan, D; Sutherland, C; van Schalkwyk, D | 1 |
Aonsri, C; Boonyalai, N; Bunsermyos, W; Chaorattanakawee, S; Dondorp, AM; Imaram, W; Imwong, M; Kosaisavee, V; Kunasol, C; Mungthin, M; Saunders, D; Suwannasin, K; Thamnurak, C | 1 |
Blanchard, A; Hine, P | 1 |
Castañeda-Mogollón, D; Kamaliddin, C; Kuhn, S; Lang, R; Pillai, DR; Toppings, NB | 1 |
Arun Kumar, K; Bhattacharyya, MK; Bhattacharyya, S; Dey, S; Fangaria, N; Padhi, S; Roy, A; Singh, P; Tabassum, W | 1 |
B Henry, N; Bolscher, JM; Bousema, T; Collins, KA; Dechering, KJ; Diarra, A; Guelbéogo, WM; Nébié, I; Ouédraogo, N; Pietro, A; S Coulibaly, A; S Sermé, S; Sirima, SB; Sombié, S; Soulama, I; T G Huijs, T; Tiono, AB; Zongo, S | 1 |
Bakshi, RP; Balta, VA; Canonizado, MA; Dziedzic, AG; Elahi, R; Jedlicka, AE; Mann, A; Mlambo, G; Nenortas, E; Owen, A; Prigge, ST; Romero-Rodriguez, K; Sayeed, A; Shapiro, TA; Sinnis, P; Stiffler, D; Sullivan, DJ; Tripathi, AK | 1 |
Chibale, K; Fidock, DA; Goldberg, DE; Istvan, ES; Lee, MCS; Llinás, M; Murithi, JM; Ottilie, S; Owen, ES; Vanaerschot, M; Winzeler, EA | 1 |
Borgans, F; Eisermann, P; Giesbrecht, K; Goetsch, U; Just-Nübling, G; Kessel, J; Lieberknecht, S; Muntau, B; Schork, J; Tappe, D; Wieters, I; Wolf, T | 1 |
Amalvict, R; Benoit, N; Chevalier, A; Delaunay, P; Fonta, I; Jeandel, PY; Madamet, M; Marty, P; Massamba, L; Mondain, V; Mosnier, J; Pomares, C; Pradines, B | 1 |
Abubaker, M; Bryce, RA; Burusco, KK; Fernández-Álvaro, E; Gutnov, A; Matthews, H; Nirmalan, N; Panwar, P; Wilkinson, J | 1 |
Arsuaga, M; Barreiro, P; de la Calle, F; de Miguel, R; Diaz, M; Loli-Ausejo, D; Tarin, EJ; Trigo, E | 1 |
Kelley, J; L'Episcopia, M; Lucchi, N; Menegon, M; Nour, BY; Nurahmed, AM; Patel, D; Perrotti, E; Ravishankar, S; Schmedes, S; Severini, C; Talha, AA; Talundzic, E | 1 |
Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
Carnino, L; Chappuis, F; Hulo, C; Konan, DB; Puppa, G | 1 |
Aydemir, O; Bailey, JA; Brazeau, NF; Gosi, P; Lin, JT; Lon, C; Marsh, PW; Moser, KA; Muller, MS; Na, YB; Park, Z; Saunders, DL; Sok, S; Spring, M; Waltmann, A; Wojnarski, M | 1 |
Blanshard, A; Hine, P | 1 |
Husen, P; Jacobsen, L; Solov'yov, IA | 1 |
Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
Abla, N; Chalon, S; Chughlay, MF; Haouala, A; Hutter, B; Lorch, U; Macintyre, F; Marie Tchouatieu, A | 1 |
Blake, LD; Iyamu, ID; Johnson, ME; Kyle, DE; Manetsch, R; McQueen, A; Shaikh, AK; Shultis, MW; Siegel, SV | 1 |
Arguin, PM; Mace, KE; Minta, AA; Tan, KR | 1 |
Maayan, N; Pace, C; Saunders, R; Sinclair, D; Tickell-Painter, M | 1 |
Burrow, R; Chis Ster, I; Kremsner, PG; Krishna, S; Staines, HM; Teo, BH | 1 |
Charunwatthana, P; Chotivanich, K; Dondorp, AM; Färnert, A; Herder, C; Holmer, E; Kiwuwa, MS; Kristensen, J; Lee, SJ; Leitgeb, AM; Lindgren, M; Moll, K; Rueangveerayut, R; Sila, P; Silamut, K; Tarning, J; Uthaisin, C; Wahlgren, M | 1 |
Amalia, E; Balogun, EO; Harada, S; Hartuti, ED; Inaoka, DK; Kita, K; Komatsuya, K; Kuroda, M; Matsuo, Y; Miller, RJ; Miyazaki, Y; Mori, M; Nozaki, T; Nugroho, NB; Prabandari, EE; Pramisandi, A; Sadikin, M; Saimoto, H; Shiba, T; Shiomi, K; Waluyo, D; Watanabe, YI; Xinying, W | 1 |
Betz, W; Bial, J; Billman, Z; Camargo, N; Campo, B; Charman, SA; Chuenchob, V; Fishbaugher, M; Flannery, EL; Foquet, L; Kappe, SH; Lee, J; Mikolajczak, SA; Murphy, SC; Navarro, MJ; Nguyen, T; Olsen, TM; Phillips, MA; Sack, BK; Saunders, J; Schafer, C; Wilson, EM | 1 |
Javelle, E; Loarer, G; Michel, R; Perisse, A; Simon, F; Velut, G | 1 |
Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
Argy, N; Houzé, S; Joste, V; Kamaliddin, C | 1 |
Akkaya, B; Aydın Teke, T; Bayhan, Gİ; Gayretli Aydın, ZG; Kaman, A; Tanır, G | 1 |
Horii, T; Tougan, T; Toya, Y; Uchihashi, K | 1 |
Buckee, CO; Catteruccia, F; Childs, LM; Holmdahl, IE; Itoe, MA; Paton, DG | 1 |
Buffet, P; Chambrion, C; Chartrel, N; Mouri, O; Ndour, PA; Roussel, C; Smith, B; Smith, P; Thellier, M; Wojnarski, M | 1 |
Bopp, SE; Bright, AT; Denchi, EL; Dharia, NV; Fidock, DA; Johnston, GL; Luna, FL; Manary, MJ; McCormack, S; McNamara, CW; Plouffe, D; Walker, JR; Winzeler, EA | 1 |
Angulo-Barturen, I; Avery, VM; Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Delves, MJ; Duffy, S; Ferrer, S; Forquer, IP; Gamo, FJ; Guy, RK; Herreros, E; Jiménez-Díaz, MB; Kelly, JX; Kocken, CHM; Kyle, DE; LaCrue, AN; Li, Y; Manetsch, R; Marfurt, J; Mather, MW; Morrisey, JM; Mutka, T; Nilsen, A; Noviyanti, R; Price, RN; Riscoe, MK; Ryan, E; Saenz, FE; Sanz, LM; Sebayang, BF; Shackleford, DM; Siegl, P; Sinden, RE; Steuten, J; Vaidya, AB; White, KL; Winter, RW; Wirjanata, G; Zeeman, AM | 1 |
Shanks, GD | 1 |
Beerahee, M | 1 |
Chulay, JD; Kremsner, PG; Looareesuwan, S | 1 |
Chulay, JD; Kremsner, PG; Scott, TR; Shanks, GD; Shapiro, TA; Sukwa, TY; van der Berg, JD | 1 |
Bellettre, X; Bouchaud, O; Michel, JF; Pull, L; Siriez, JY | 1 |
Berrevoets, MA; Dofferhoff, AS; Meis, JF; Sprong, T | 1 |
De Castro, N; Gallien, S; Hamane, S; Molina, JM; Taieb, F | 1 |
Bloch, M; Bouchaud, O; Bourée, P; Cailhol, J; Campa, P; Consigny, PH; Cordel, H; Fain, O; Godineau, N; Gros, H; Matheron, S; Ralaimazava, P | 1 |
Bastiaens, GJ; Boulaksil, M; de Mast, Q; Gunasekera, A; Hoffman, SL; Pop, G; Sauerwein, RW; van der Ven, AJ; van Meer, MP | 1 |
David, K; Møller, CH | 1 |
Clain, J; Cottrell, G; Hubert, V; Le Bras, J; Musset, L | 1 |
Almelli, T; Basco, LK; Debue, C; Djaman Allico, J; Foumane Ngane, V; Tahar, R; Whegang Youdom, S | 1 |
Amore, A; Calitri, C; Camilla, R; Garazzino, S; Peruzzi, L; Tovo, PA | 1 |
Hickman, MR; Li, Q; Melendez, V; Miller, SR; Ogutu, B; Otieno, W; Polhemus, M; Remich, S; Smith, B; Teja-Isavadharm, P; Weina, PJ | 1 |
Dondorp, AM; Maude, RJ; Nguon, C; White, LJ; White, NJ | 1 |
Akhoon, BA; Gupta, SK; Shukla, Y; Singh, KP; Varshney, M | 1 |
Grynberg, S; Kopel, E; Lachish, T; Meltzer, E; Schwartz, E | 1 |
Chai, JY; Choi, JS; Je, JH; Jung, BK; Kim, MJ; Lee, HJ; Na, YJ; Park, SH; Seo, JH; Song, JY | 1 |
Akala, HM; Bulimo, WD; Eyase, FL; Imbuga, MO; Ingasia, LA; Johnson, JD; Kamau, E; Opot, BH | 1 |
Alves Dos Santos, R; de Oliveira Silva, E; Dos Santos Gonçalves, N; Jacometti Cardoso Furtado, NA | 1 |
Callens, S; Donck, J; Ommeslag, D; Rogge, S; Van Acker, J; Vantomme, B | 1 |
Dinter, D; Domijan, AM; Gajski, G; Garaj-Vrhovac, V | 1 |
Croft, AM; Jacquerioz, FA | 2 |
Harris, DM; Matcha, GV; Steele, HP | 1 |
Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Gregory, C; Ittiverakul, M; Kuntawunginn, W; Lanteri, C; Lon, C; Prom, S; Saunders, DL; Somethy, S; Spring, MD | 1 |
Lachish, T; Schwartz, E | 1 |
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
Barata, L; Boutbibe, K; Clain, J; Franetich, JF; Houzé, P; Mazier, D; Zanghi, G | 1 |
Arguin, PM; Barnwell, JW; Biliya, S; Halsey, ES; Plucinski, MM; Silva-Flannery, LM; Talundzic, E; Udhayakumar, V; Vannberg, F | 1 |
Bergman, LW; Daly, TM; Jenkins, BJ; Mather, MW; Morrisey, JM; Vaidya, AB | 1 |
Bouchaud, O; Bruneel, F; Camus, C; Caumes, E; Choquet, C; Corne, P; Durand, R; Gibot, S; Girard, PM; Houze, S; Huisse, MG; Kalloumeh, A; Le Bras, J; Matheron, S; Megarbane, B; Mira, JP; Peytel, E; Roy, C; Simon, F; Tubach, F; Villers, D; Wolff, M | 1 |
Forquer, IP; Kelly, JX; Li, Y; Morrisey, JM; Nilsen, A; Pou, S; Riscoe, MK; Smilkstein, MJ; Stickles, AM; Vaidya, AB; Winter, RW | 1 |
Aprahamian, A; Argy, N; Aurégan, C; Cheron, G; Clain, J; Hubert, V | 1 |
Deakin, J; Idris-Usman, M; Matthews, H; Nirmalan, NJ; Rajab, M | 1 |
Banura, P; Guler, JL; Houpt, E; Huang, F; Jacob, ST; Laufer, MK; Liu, J; Moore, CC; Pholwat, S; Stroup, S | 1 |
Ogutu, B; Otieno, W; Polhemus, ME; Remich, SA; Walsh, DS | 1 |
Berens-Riha, N; Eshetu, T; Girma, T; Gürkov, R; Hempel, JM; Krause, E; Löscher, T; Mamo, Y; Miranda, IB; Schmidt, M | 1 |
Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
Burke, M; Chiodini, PL; Fivelman, QL; Klein, JL; Laundy, M; Pasvol, G; Price, N; Sutherland, CJ | 1 |
bin Reza, F; Chiodini, PL; Doherty, JF; Fifer, H; Gothard, P; Haustein, T; Nicholas, M; Njimgye-Tekumafor, NE; Pearce, RJ; Polley, SD; Sutherland, CJ | 1 |
Boggild, AK; Kain, KC; Katz, K; Krudsood, S; Liles, WC; Looareesuwan, S; Patel, SN; Serghides, L; Tangpukdee, N; Wilairatana, P | 1 |
Eaton, L | 1 |
Batty, AJ; Jones, ME; Zuckerman, JN | 1 |
Gan, LS; Loh, JP | 1 |
Schofield, S; Tepper, M | 1 |
Berens-Riha, N; Eshetu, T; Fekadu, S; Gürkov, R; Hölscher, M; Löscher, T; Miranda, IB; Tadesse, Z | 1 |
Forestier, E; Labe, A; Lecomte, C; Raffenot, D; Rogeaux, O | 1 |
Ganesan, SM; Ke, H; Laroiya, K; Mather, MW; Morrisey, JM; Painter, HJ; Phillips, MA; Rathod, PK; Vaidya, AB | 1 |
Terlouw, DJ; van Eijk, AM | 1 |
Bautista, JM; Diez, A; García-Granados, A; Marín-García, P; Moneriz, C; Puyet, A | 1 |
Baron, S; Contentin, L; Desoubeaux, G; Grammatico-Guillon, L; Thanh, HD | 1 |
Clemens, EG; Deye, GA; Dumler, JS; Fracisco, S; Macareo, L; Magill, AJ; Miller, L; Miller, RS; Murphy, J; Salas, CJ; Smith, BL; Sousa, JC; Tosh, D | 1 |
Lewthwaite, P; Uriel, A | 1 |
Barón, C; Carrasquilla, G; Cousin, M; Fisher, LM; Lefèvre, G; Monsell, EM; Sander, O; Walter, V | 1 |
Kikuchi, T; Kimura, M; Koga, M; Maruyama, H; Miura, T | 1 |
Benoit, N; Bouchiba, H; Briolant, S; Desbordes, M; Marin-Jauffre, A; Martelloni, M; Pascual, A; Pommier de Santi, V; Pradines, B; Richa, G; Taudon, N; Wurtz, N | 1 |
Becher, G; Wylie, G | 1 |
Ariey, F; Bjorge, S; Chea, N; Christophel, EM; Duong, S; Habib, N; Hoyer, S; Kheng, S; Khim, N; Kim, S; Mellor, S; Menard, D; Newman, RD; Nguon, S; Ros, S; Sophal, U; Sum, S; Thompson, MM; Thomson, A; Top, S; Witkowski, B; Yeang, C; Yeung, S; Yok, S | 1 |
Borrmann, S; Erkens, MA; Graumans, W; Heinrichs, MJ; Hermsen, CC; Hoffman, SL; Luty, AJ; Nganou-Makamdop, K; Roestenberg, M; Rozier, YP; Sauerwein, RW; Scholzen, A; Siebelink-Stoter, R; Sim, BK; Teelen, K; Teirlinck, AC; van de Vegte-Bolmer, M; van Gemert, GJ; van Lieshout, L; Visser, LG; Vos, MW | 1 |
Abong'o, D; Bayoh, MN; Desai, M; Gimnig, JE; Hamel, MJ; Kariuki, S; Kosgei, J; Lobo, NF; Marwanga, D; Olang, G; Ombok, M; Otieno, P; Vulule, J; Walker, ED; Williamson, J | 1 |
Kaiser, A; Maier, W | 1 |
Sehdev, PS | 1 |
Baird, JK; Bangs, MJ; Barcus, MJ; Chulay, JD; Fryauff, DJ; Gramzinski, R; Hoffman, SL; Jones, TR; Kumusumangsih, M; Lacy, M; Ling, J; Maguire, JD; Miller, GB; Sismadi, P | 1 |
Schau, A; Winkler, C; Ziegler, T | 1 |
Fourcade, L; Heno, P; Hovette, P; Paule, P; Pradines, B; Touze, JE | 1 |
Camus, D; Delhaes, L; Dutoit, E; Inglebert, P; Masson, V | 1 |
Djossou, F; Etienne, G; Le Bras, M; Longy-Boursier, M; Malvy, D; Pistone, T; Vatan, R | 1 |
Delmont, J | 2 |
Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Chulay, JD; Fryauff, DJ; Gramzinski, R; Hoffman, SL; Lacy, MD; Ling, J; Maguire, JD; Miller, GB; Sismadi, P | 1 |
Brockman, A; Leonardi, E; Looareesuwan, S; McGready, R; Nosten, F; Phaipun, L; Slight, T; Thway, KL; van Vugt, M; Villegas, L; White, NJ | 1 |
Butcher, GA; Sinden, RE | 1 |
Berezcky, S; Berqvist, Y; Björkman, A; Färnert, A; Gil, P; Lindberg, J; Lindegårdh, N; Swedberg, G; Thapar, MM | 1 |
McKeage, K; Scott, L | 1 |
Alifrangis, M; Jelinek, T; Salanti, A; Schwöbel, B | 1 |
Bricaire, F; Danis, M | 1 |
Dupouy-Camet, J; Tourte-Schaeffer, C; Yera, H | 1 |
Kain, KC | 1 |
Crabb, C | 1 |
Bujanover, S; Kain, KC; Schwartz, E | 1 |
Ensom, MH; Marra, F; Salzman, JR | 1 |
Cho, T; Edstein, MD; Gilveray, G; Looareesuwan, S; McGready, R; Nosten, F; Stepniewska, K; White, NJ | 1 |
Basco, LK | 1 |
Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
Fischer, PR; Stauffer, W | 1 |
Bagaphou, T; Binder, RK; Borrmann, S; Faucher, JF; Kremsner, PG; Lell, B; Matsiegui, PB; Miller, G; Missinou, MA; Pabisch, S; Rezbach, P | 1 |
Alifrangis, M; Bygbjerg, IB; David, KP; Rønn, A; Salanti, A; Vestergaard, LS | 1 |
Bienzle, U; Ehrhardt, S; Jelinek, T; Mockenhaupt, FP; Muehlen, M; Otchwemah, R; Schreiber, J | 1 |
Binh, TQ; de Vries, PJ; Giao, PT; Hung, le Q; Kager, PA; Nam, NV | 1 |
Gruss, H; Jelinek, T; Mockenhaupt, FP; Muehlen, M; Suttorp, N; Wichmann, O | 1 |
Arizono, N; Kajita, Y; Murakami, S; Okamoto, A; Sato, K; Tegoshi, T; Uchiyama, H; Yamada, T; Yoneda, S | 1 |
Alifrangis, M; Beran, J; Bisoffi, Z; Cuadros, J; da Cunha, S; Ehrhardt, S; Fry, G; Gascon, J; Gjorup, I; Grobusch, MP; Hatz, C; Jelinek, T; Kern, P; Kollaritsch, H; Laferl, H; Matteelli, A; McWhinney, P; Muehlberger, N; Muhlen, M; Peyerl-Hoffmann, G; Richter, J; Schulze, M; Wichmann, O | 1 |
Björkman, A; Gil, JP; Thapar, MM | 1 |
Ayuo, PO; Esamai, F; Jakait, B; Obala, A; Ong'or, WO; Tenge, CN | 1 |
Gill, MJ; Kain, KC; Kuhn, S | 1 |
Kioy, D; Konsil, J; Manyando, C; Miller, GB; Mulenga, M; Na-Bangchang, K; Ruengweerayut, R | 1 |
Ashley, EA; Barends, M; Cho, T; Hutagalung, R; Looareesuwan, S; McGready, R; Moo, E; Nosten, F; White, NJ | 1 |
Gupta, RK; Looareesuwan, S; Nosten, F; Paiphun, L; Slight, T; Van Vugt, M; White, NJ | 1 |
Anderson, KL; Edstein, MD; Good, MF; Kotecka, BM; Kyle, DE; Pombo, DJ; Rieckmann, KH | 1 |
Petersen, JE | 1 |
Orton, L; Osei-Akoto, A; Owusu-Ofori, SP | 1 |
Kain, KC; Patel, SN | 1 |
Bigot, P; Durand, R; Le Bras, J; Musset, L; Parzy, D; Pradines, B | 1 |
Cho, T; Gilveray, G; Looareesuwan, S; McGready, R; Nosten, F; Stepniewska, K; Ward, SA; White, NJ | 1 |
Benchimol, C; Bernardino, L; Bom, J; do Rosário, V; Nogueira, F; Pimentel, S; Quinhentos, V; Varandas, L | 1 |
Bourée, P | 1 |
Benoit-Vical, F; Berry, A; Fabre, R; Lelièvre, J; Magnaval, JF; Marchou, B; Senescau, A | 1 |
Berzins, K; Grandien, A; Hagstedt, M; Nyakeriga, AM; Perlmann, H; Perlmann, P; Troye-Blomberg, M; Zhivotovsky, B | 1 |
Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P | 1 |
Bouchaud, O; Le Bras, J; Massias, L; Matheron, S; Musset, L | 1 |
Folarin, OA; Gbotosho, GO; Happi, CT; Kyle, DE; Milhous, WK; Milner, D; Oduola, AM; Sarr, O; Sowunmi, A; Wirth, DF | 1 |
Alloueche, A; Bennett, S; Fielding, K; Greenwood, BM; Malunga, F; Mulenga, M; Shulman, C; Thuma, PE | 1 |
Hitani, A; Kimura, M; Nakamura, T; Nawa, Y; Ohtomo, H | 1 |
Boggild, AK; Kain, KC; Lewis, LS; Parise, ME | 1 |
Iwagami, M; Kano, S; Kawazu, S; Looareesuwan, S; Naoshima-Ishibashi, Y | 1 |
Boggild, AK; Kain, KC; Krudsood, S; Leowattana, W; Looareesuwan, S; Patel, SN; Pornpininworakij, K; Tangpukdee, N; Thanachartwet, W | 1 |
Bouchier, C; Carme, B; Demar, M; Ekala, MT; Esterre, P; Fandeur, T; Legrand, E; Puijalon, OM; Quinternet, M; Rogier, C; Volney, B | 1 |
Clain, J; Le Bras, J; Musset, L | 1 |
Burgner, D; Cherian, S | 1 |
Kessl, JJ; Meshnick, SR; Trumpower, BL | 1 |
Ansari, MJ; Garapati, S; Iroegbu, N; Okoli, O; Spear, JB; Wongba, W | 1 |
Exner, B; Kollaritsch, H; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH | 1 |
Kollaritsch, H; Noedl, H; Parizek, M; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH | 1 |
Khositnithikul, R; Mungthin, M; Tan-Ariya, P | 1 |
Bouchaud, O; Cailhol, J; Durand, R; Hubert, V; Le Bras, J; Massias, L; Prendki, V; Ralaimazava, P | 1 |
Ballou, WR; Heppner, DG; Lievens, M; Ogutu, B; Polhemus, ME; Remich, S; Waitumbi, J | 1 |
Angoulvant, F; Bigirimana, Z; Blondé, R; Bourdon, O; Bourrillon, A; D'Ortenzio, E; Faye, A; Fenneteau, O; Holvoet, L; Le Bras, J; Lorrot, M; Matheron, S; Naudin, J; Vitoux, C | 1 |
Kain, KC; Le Saux, N; McCarthy, AE; Rose, GW; Suh, KN | 1 |
Ager, AL; Canfield, CJ; Jacobus, DP; Lewis, NJ; Milhous, WK; Rossan, RN; Sweeney, TR | 1 |
Canfield, CJ; Hutchinson, DB; Kyle, DE; Looareesuwan, S; Viravan, C; Webster, HK | 1 |
Hutchinson, D; Kremsner, PG; Nkeyi, M; Philipps, J; Radloff, PD | 1 |
Birley, H; Chiodini, PL; Conlon, CP; Farquhar, JA; Hall, AP; Hutchinson, DB; Peto, TE; Warrell, DA | 1 |
Canfield, CJ; Eaves, CJ; Hussein, Z; Hutchinson, DB | 1 |
Canfield, CJ; Eaves, J; Hussein, Z; Hutchinson, DB | 1 |
Yeo, AE | 1 |
Edstein, MD; Rieckmann, KH; Yeo, AE | 1 |
Edstein, MD; Kyle, DE; Looareesuwan, S; Viravan, C | 1 |
Basco, LK; Ringwald, P | 1 |
Fourcade, L; Touze, JE | 1 |
Aleman, GM; Gordon, DM; Klotz, FW; Oloo, AJ; Sadie, D; Scott, TR; Shanks, GD | 1 |
Whitty, CJ | 1 |
Bustos, DG; Canete-Miguel, E; Canfield, CJ; Hutchinson, DB | 1 |
Barditch-Crovo, P; Kumar, N; Ranasinha, CD; Shapiro, TA | 1 |
Chisdaka, N; Mulenga, M; Roskell, NS; Scott, TR; Sukwa, TY | 1 |
Canfield, CJ; Chalermarut, K; Hutchinson, DB; Looareesuwan, S; Rattanapong, Y; Wilairatana, P | 1 |
Canfield, CJ; Chulay, JD; Hutchinson, DB; Looareesuwan, S | 1 |
Anabwani, G; Canfield, CJ; Hutchinson, DB | 1 |
Duvenage, CS; Roskell, NS; Scott, TR; van der Berg, JD | 1 |
White, N | 1 |
Watt, G | 1 |
Dragsted, UB; Lundgren, JD | 1 |
Nosten, F | 1 |
Camus, D; Chulay, JD; Clarke, PD; Günther, M; Høgh, B; Joubert, I; Kain, KC; Nothdurft, HD; Overbosch, D; Roskell, NS; Shaw, D | 1 |
Brugha, R; Shretta, R; Snow, R; Walt, G | 1 |
Kain, KC; Keystone, JS; Shanks, GD | 1 |
Beck, B; Blum, J; Funk, M; Furrer, H; Genton, B; Hatz, FR; Holzer, B; Loutan, L; Markwalder, K; Raeber, PA; Schlagenhauf, P; Siegl, G; Steffen, R; Stürchler, D; Wyss, R | 1 |
Campos, P; Canfield, CJ; Clendenes, M; Hutchinson, DB; Llanos-Cuentas, A | 1 |
Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Fryauff, DJ; Gramzinski, R; Hoffman, SL; Jones, TR; Kusumaningsih, M; Lacy, MD; Ling, J; Maguire, JD; Sismadi, P; Wiady, I | 1 |
World, MJ | 1 |
Gatton, ML; Hogarth, W; Saul, A | 1 |
Adagu, IS; Butcher, GA; Fivelman, QL; Pasvol, G; Warhurst, DC | 1 |
Dickins, M; Ginger, CD; Gutteridge, WE; Holdich, T; Hudson, AT; Hutchinson, DB; Latter, VS; Pudney, M; Randall, AW | 1 |
32 review(s) available for atovaquone and Malaria, Falciparum
Article | Year |
---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Antimalarial application of quinones: A recent update.
Topics: Antimalarials; Dose-Response Relationship, Drug; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinones; Structure-Activity Relationship | 2021 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Cameroon; Child; Colombia; Drug Combinations; Ethiopia; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Randomized Controlled Trials as Topic; Thailand; Treatment Failure | 2021 |
Mefloquine for preventing malaria during travel to endemic areas.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel-Related Illness | 2017 |
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
Topics: Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Electron Transport Complex III; Humans; Malaria, Falciparum; Malaria, Vivax; Mutation; Plasmodium falciparum; Proguanil; Travel; Treatment Failure | 2018 |
Clinical pharmacology of atovaquone and proguanil hydrochloride.
Topics: Animals; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Activation; Humans; Intestinal Absorption; Intestinal Mucosa; Lymphocytes; Malaria; Malaria, Falciparum; Malaria, Vivax; Proguanil | 1999 |
Atovaquone and proguanil hydrochloride for treatment of malaria.
Topics: Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Travel | 1999 |
Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
Topics: Animals; Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Randomized Controlled Trials as Topic; Travel; Treatment Outcome | 1999 |
WITHDRAWN: Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2015 |
Drugs for preventing malaria in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
[New strategies in therapy to roll back malaria].
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Metabolic Clearance Rate; Naphthoquinones; Proguanil; Risk Factors; Travel | 2002 |
Atovaquone/proguanil for plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Atovaquone; Controlled Clinical Trials as Topic; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil | 2002 |
[Value of malarone in therapy of malaria tropica].
Topics: Animals; Antimalarials; Atovaquone; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil; Randomized Controlled Trials as Topic | 2002 |
[Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
Topics: Animals; Antimalarials; Atovaquone; DNA Replication; DNA, Protozoan; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mitochondria; Naphthoquinones; Organelles; Plasmodium falciparum; Proguanil | 2002 |
[Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Child; Humans; Malaria, Falciparum; Middle Aged; Naphthoquinones; Patient Compliance; Proguanil; Travel | 2002 |
[What is the value of the combination atovaquone-proguanil for the clinician?].
Topics: Animals; Antimalarials; Atovaquone; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil; Travel | 2002 |
Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Atovaquone; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Travel | 2003 |
The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Resistance, Multiple; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthoquinones; Proguanil; Sesquiterpenes | 2003 |
Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria.
Topics: Antimalarials; Atovaquone; Drug Administration Schedule; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Randomized Controlled Trials as Topic; Travel | 2003 |
Atovaquone-proguanil for prophylaxis and treatment of malaria.
Topics: Antimalarials; Atovaquone; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil | 2003 |
[Malaria chemoprophylaxis].
Topics: Antimalarials; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Pregnancy; Proguanil; Risk Assessment; Travel | 2005 |
Atovaquone-proguanil for treating uncomplicated malaria.
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Randomized Controlled Trials as Topic | 2005 |
Atovaquone/proguanil for the prophylaxis and treatment of malaria.
Topics: Animals; Atovaquone; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil | 2005 |
Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Atovaquone; Electron Transport Complex III; Enzyme Inhibitors; Humans; Malaria, Falciparum; Models, Molecular; Molecular Sequence Data; Plasmodium falciparum; Pneumocystis carinii; Pneumonia, Pneumocystis; Sequence Alignment; Toxoplasma; Toxoplasmosis; Yeasts | 2007 |
[Malarone: newcomer in the treatment of malaria].
Topics: Antimalarials; Atovaquone; Chloroquine; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Resistance; Drug Tolerance; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil | 1997 |
Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
Topics: Adult; Aged; Antimalarials; Atovaquone; Child; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Randomized Controlled Trials as Topic | 1999 |
[Atovaquone/proguanil. Prophylaxis and treatment of malaria].
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil | 2000 |
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
Topics: Animals; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Resistance; Health Planning Guidelines; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Primaquine; Proguanil | 2001 |
[Malaria--chemoprophylaxis 2001].
Topics: Africa; Antimalarials; Asia; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Proguanil; South America; Switzerland; Travel | 2001 |
[symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
Topics: Antimalarials; Atovaquone; Drug Administration Schedule; Drug Combinations; Endemic Diseases; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Travel | 2001 |
38 trial(s) available for atovaquone and Malaria, Falciparum
Article | Year |
---|---|
Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.
Topics: Amodiaquine; Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Proguanil; Treatment Outcome | 2022 |
Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Area Under Curve; Atovaquone; Binding, Competitive; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythrocytes; Female; Heparin; Heparitin Sulfate; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Merozoites; Middle Aged; Parasite Load; Parasitemia; Plasmodium falciparum; Proguanil; Severity of Illness Index | 2017 |
Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Atovaquone; Cameroon; Child, Preschool; Cytochromes b; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Treatment Outcome | 2014 |
Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
Topics: Activation, Metabolic; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chromatography, Liquid; Drug Combinations; Drug Compounding; Drug Monitoring; Female; Half-Life; Humans; Infusions, Intravenous; Kenya; Malaria, Falciparum; Male; Mass Spectrometry; Middle Aged; Proguanil; Reticulocytes; Young Adult | 2014 |
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial.
Topics: Adolescent; Adult; Artemether; Artemisinins; Atovaquone; Audiometry; Child; Ethanolamines; Ethiopia; Female; Fluorenes; Hearing Loss, Sensorineural; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Proguanil; Quinine | 2008 |
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult | 2009 |
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
Topics: Adult; Antimalarials; Area Under Curve; Atovaquone; Chemoprevention; Cohort Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Placebos; Plasmodium falciparum; Proguanil; Sporozoites | 2012 |
Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Audiometry; Child; Colombia; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Atovaquone; Genotype; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Proguanil; Treatment Outcome; Young Adult | 2013 |
Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Child; Double-Blind Method; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Transients and Migrants; Treatment Outcome | 2002 |
Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Proguanil; Treatment Outcome | 2002 |
Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Plasmodium falciparum; Proguanil; Sesquiterpenes; Treatment Failure | 2002 |
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Naphthoquinones; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Proguanil; Sesquiterpenes; Thailand | 2003 |
Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children.
Topics: Amodiaquine; Animals; Antimalarials; Atovaquone; Child; Drug Combinations; Drug Tolerance; Female; Humans; Infant; Malaria, Falciparum; Male; Naphthoquinones; Proguanil; Treatment Outcome | 2003 |
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Primaquine; Proguanil; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam | 2004 |
A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria.
Topics: Administration, Oral; Adolescent; Adult; Atovaquone; Child; Child, Preschool; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Kenya; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Prognosis; Proguanil; Quinine; Risk Assessment; Severity of Illness Index; Single-Blind Method; Survival Analysis; Treatment Outcome | 2005 |
The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
Topics: Adolescent; Adult; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Malaria, Falciparum; Naphthoquinones; Pregnancy; Proguanil; Thailand; Triazines; Zambia | 2005 |
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Naphthoquinones; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proguanil; Quinine; Sesquiterpenes; Thailand | 2005 |
Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Therapy, Combination; Electrocardiography; Female; Heart Diseases; Humans; Long QT Syndrome; Malaria, Falciparum; Male; Middle Aged; Myanmar; Myocardium; Naphthoquinones; Plasmodium falciparum; Proguanil; Sesquiterpenes; Thailand; Treatment Outcome | 2005 |
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid; Hematinics; Humans; Infant; Malaria, Falciparum; Naphthoquinones; Parasitemia; Population Density; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Failure; Zambia | 2006 |
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prevalence; Proguanil; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia | 2006 |
Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Proguanil; Thailand | 2007 |
Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Humans; Kaplan-Meier Estimate; Kenya; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Proguanil; Time Factors | 2008 |
Atovaquone and proguanil for Plasmodium falciparum malaria.
Topics: Acute Disease; Adult; Amodiaquine; Antimalarials; Atovaquone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gabon; Humans; Malaria, Falciparum; Male; Naphthoquinones; Proguanil; Time Factors; Treatment Outcome | 1996 |
Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Administration Schedule; Evaluation Studies as Topic; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Treatment Outcome | 1995 |
Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Proguanil | 1996 |
Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum.
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Atovaquone; Child; Child, Preschool; Computer Simulation; Databases, Factual; Dose-Response Relationship, Drug; Female; Gabon; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Models, Biological; Naphthoquinones; Philippines; Thailand; Zambia | 1997 |
Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Humans; Intestinal Absorption; Malaria, Falciparum; Male; Metabolic Clearance Rate; Naphthoquinones; Proguanil | 1996 |
Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Proguanil; Treatment Outcome | 1998 |
Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Malaria, Falciparum; Naphthoquinones; Philippines; Proguanil; Pyrimethamine; Sulfadoxine | 1999 |
Prophylactic activity of atovaquone against Plasmodium falciparum in humans.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Atovaquone; Double-Blind Method; Humans; Insect Bites and Stings; Malaria, Falciparum; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction | 1999 |
A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Zambia | 1999 |
Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Proguanil; Thailand; Treatment Outcome | 1999 |
Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.
Topics: Acute Disease; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Therapy, Combination; Feces; Female; Humans; Malaria, Falciparum; Male; Naphthoquinones; Phenanthrenes; Plasmodium falciparum; Proguanil; Treatment Outcome | 1999 |
Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.
Topics: Adult; Antimalarials; Atovaquone; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Proguanil; South Africa | 1999 |
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
Topics: Adolescent; Adult; Aged; Antimalarials; Anxiety; Atovaquone; Chloroquine; Dizziness; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Proguanil; Travel; Treatment Outcome | 2000 |
Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Middle Aged; Naphthoquinones; Peru; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Child; Drug Combinations; Female; Humans; Indonesia; Malaria, Falciparum; Male; Methemoglobinemia; Middle Aged; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Primaquine; Proguanil; Treatment Outcome | 2001 |
155 other study(ies) available for atovaquone and Malaria, Falciparum
Article | Year |
---|---|
High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
Topics: Animals; Biological Assay; Child, Preschool; DNA, Protozoan; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Female; Humans; Indoles; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy | 2007 |
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
Topics: Animals; Antimalarials; Atovaquone; Comoros; Drug Resistance; France; Genotype; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Travel; Treatment Failure | 2008 |
Synthesis and antimalarial activity of new atovaquone derivatives.
Topics: Antimalarials; Atovaquone; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2009 |
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2010 |
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Female; Hep G2 Cells; Humans; Malaria, Falciparum; Mice; Mice, Inbred ICR; Nuclear Magnetic Resonance, Biomolecular; Parasitemia; Plasmodium falciparum; Quinolines; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2012 |
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl[1,4]naphthoquinones and their activity against the human malaria parasite Plasmodium falciparum (3D7).
Topics: Antimalarials; Cells, Cultured; Flow Cytometry; Humans; Indolequinones; Malaria, Falciparum; Molecular Structure; Naphthoquinones; Plasmodium falciparum; Sulfhydryl Compounds | 2013 |
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
Topics: Animals; Antimalarials; Benzimidazoles; Biological Availability; Cell Line, Tumor; Cell Survival; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mice; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship | 2014 |
Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Molecular Docking Simulation; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2015 |
Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
Topics: Animals; Antimalarials; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Survival; Female; Humans; Jurkat Cells; Malaria, Falciparum; Mice; Microsomes, Liver; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazines; Structure-Activity Relationship | 2015 |
Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.
Topics: Animals; Antimalarials; High-Throughput Screening Assays; Humans; In Vitro Techniques; Malaria; Malaria, Falciparum; Mice; Mice, SCID; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Serine Proteinase Inhibitors; Structure-Activity Relationship; Triazoles | 2015 |
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
Topics: Amides; Animals; Antimalarials; Boron Compounds; Dogs; Female; Humans; Malaria; Malaria, Falciparum; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2017 |
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins | 2018 |
Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions.
Topics: Antimalarials; Azides; Copper; Cycloaddition Reaction; Hep G2 Cells; Humans; Life Cycle Stages; Malaria, Falciparum; Plasmodium falciparum; Quinolines | 2021 |
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan | 2021 |
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials.
Topics: Administration, Oral; Animals; Antimalarials; Humans; Malaria, Falciparum; Mice; Molecular Structure; Plasmodium falciparum; Quinazolinones; Structure-Activity Relationship | 2021 |
Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects.
Topics: Antimalarials; Atovaquone; Drug Combinations; Healthy Volunteers; Humans; Ketoconazole; Malaria, Falciparum; Proguanil | 2022 |
Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Female; Malaria; Malaria, Falciparum; Plasmodium; Plasmodium falciparum | 2022 |
Mitochondrially targeted proximity biotinylation and proteomic analysis in Plasmodium falciparum.
Topics: Antimalarials; Atovaquone; Biotinylation; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Proteomics | 2022 |
Transcriptional changes in Plasmodium falciparum upon conditional knock down of mitochondrial ribosomal proteins RSM22 and L23.
Topics: Antimalarials; Atovaquone; DNA, Mitochondrial; Electron Transport Complex III; Humans; Malaria, Falciparum; Mitochondria; Mitochondrial Proteins; Plasmodium; Plasmodium falciparum; Ribosomal Proteins; RNA, Ribosomal; Transcription, Genetic | 2022 |
Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study.
Topics: Adult; Antimalarials; Atovaquone; Cohort Studies; Colorectal Neoplasms; Drug Combinations; Humans; Malaria, Falciparum; Proguanil | 2022 |
Creating and Validating Ligase Primers to Detect Single Nucleotide Polymorphisms Associated with Atovaquone Resistance in Plasmodium falciparum.
Topics: Antimalarials; Atovaquone; Cytochromes b; DNA Primers; Drug Combinations; Drug Resistance; Humans; Ligases; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Proguanil | 2023 |
In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand.
Topics: Antimalarials; Atovaquone; Cytochromes b; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Thailand | 2023 |
Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria, Falciparum; Proguanil | 2023 |
Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum.
Topics: Antimalarials; Atovaquone; Canada; Drug Combinations; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Recurrence; Sepharose; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2023 |
Topics: Animals; Atovaquone; DNA, Mitochondrial; Endodeoxyribonucleases; Humans; Malaria; Malaria, Falciparum; Parasites; Plasmodium falciparum; Protozoan Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2023 |
Assessment of the transmission blocking activity of antimalarial compounds by membrane feeding assays using natural Plasmodium falciparum gametocyte isolates from West-Africa.
Topics: Africa, Western; Animals; Antimalarials; Atovaquone; Folic Acid Antagonists; Humans; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito.
Topics: Animals; Anopheles; Antimalarials; Antiparasitic Agents; Atovaquone; Humans; Malaria; Malaria, Falciparum; Mice; Parasites; Plasmodium falciparum; Vaccines | 2023 |
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.
Topics: Antimalarials; Atovaquone; Drug Design; Electron Transport Chain Complex Proteins; Humans; Life Cycle Stages; Malaria, Falciparum; Metabolome; Metabolomics; Mitochondria; Plasmodium falciparum; Quinolines | 2020 |
Two cases of airport-associated falciparum malaria in Frankfurt am Main, Germany, October 2019.
Topics: Adult; Airports; Antimalarials; Artesunate; Atovaquone; Fever; Genotype; Germany; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Travel; Treatment Outcome | 2019 |
Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Topics: Antimalarials; Artemisinins; Atovaquone; Codon; Congo; Cytochromes b; Drug Combinations; Drug Resistance; Female; France; Humans; Malaria, Falciparum; Middle Aged; Mutation; Phenanthrenes; Plasmodium falciparum; Proguanil; Quinolines; Tetrahydrofolate Dehydrogenase; Travel | 2020 |
Lead Optimization of Dehydroemetine for Repositioned Use in Malaria.
Topics: Antimalarials; Atovaquone; Cell Line, Tumor; Drug Repositioning; Drug Resistance, Multiple; Drug Synergism; Emetine; Female; Hep G2 Cells; Humans; Malaria, Falciparum; Male; Membrane Potential, Mitochondrial; Plasmodium falciparum; Proguanil; Stereoisomerism | 2020 |
A case of acute generalized exanthematous pustulosis caused by exposure to Atovaquone/proguanil.
Topics: Acute Generalized Exanthematous Pustulosis; Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Proguanil | 2020 |
Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol.
Topics: Africa; Anti-Infective Agents; Antimalarials; Artemisinins; Atovaquone; Cytochromes b; DNA, Protozoan; Drosophila Proteins; Drug Combinations; Drug Resistance; Genotype; High-Throughput Nucleotide Sequencing; Humans; Italy; Malaria, Falciparum; Microfilament Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Prevalence; Proguanil; Protozoan Proteins; Travel | 2020 |
A Case report of atovaquone/proguanil induced esophageal ulcers.
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria, Falciparum; Proguanil; Ulcer | 2020 |
Selection of Cytochrome
Topics: Antimalarials; Atovaquone; Cambodia; Cytochromes b; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil | 2021 |
Inhibition Mechanism of Antimalarial Drugs Targeting the Cytochrome bc
Topics: Antimalarials; Atovaquone; Cytochromes; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum | 2021 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Cytochromes b; DNA, Protozoan; Drug Resistance; Female; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Mutation; Naphthoquinones; Plasmodium berghei; Plasmodium falciparum | 2017 |
Acute malaria infection after atovaquone-proguanil prophylaxis.
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Proguanil; Travel | 2017 |
Biochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate:quinone oxidoreductase, a potential drug target.
Topics: Antimalarials; Atovaquone; Biocatalysis; Coumarins; Drug Synergism; Enzyme Inhibitors; Humans; Malaria, Falciparum; Malates; Mitochondrial Membranes; Oxaloacetic Acid; Oxidoreductases; Plasmodium falciparum; Protozoan Proteins | 2018 |
Assessing drug efficacy against Plasmodium falciparum liver stages in vivo.
Topics: Animals; Antimalarials; Atovaquone; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Liver; Malaria, Falciparum; Mice; Plasmodium falciparum; Proguanil; Pyrimidines; Triazoles | 2018 |
Treatment for Uncomplicated Plasmodium falciparum Malaria in French Soldiers Deployed in Sub-Saharan Africa: Gaps Between Policy and Field Practice.
Topics: Adult; Antimalarials; Artemisinins; Atovaquone; Central African Republic; Drug Combinations; Female; France; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Male; Middle Aged; Physicians; Proguanil; Retrospective Studies; Surveys and Questionnaires | 2018 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |
[Fluindione and falciparum malaria treated by atovaquone-proguanil].
Topics: Anticoagulants; Antimalarials; Atovaquone; Drug Combinations; Drug Interactions; Female; Heart Valve Prosthesis Implantation; Humans; Malaria, Falciparum; Middle Aged; Phenindione; Proguanil; Thrombosis; Travel | 2018 |
A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone-Proguanil.
Topics: Adult; Animals; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Recurrence; Travel; Uganda | 2018 |
Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
Topics: Antimalarials; Atovaquone; Automation, Laboratory; Chloroquine; Drug Discovery; Hematology; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Schizonts; Trophozoites | 2019 |
Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission.
Topics: Africa; Animals; Anopheles; Antimalarials; Atovaquone; Cytochromes b; Female; Insecticide-Treated Bednets; Malaria, Falciparum; Models, Biological; Mosquito Control; Mosquito Vectors; Plasmodium falciparum; Time Factors | 2019 |
Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Young Adult | 2019 |
Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen families.
Topics: Antigenic Variation; Antigens; Atovaquone; Cytochromes b; Drug Resistance, Multiple; Evolution, Molecular; Genome, Protozoan; High-Throughput Nucleotide Sequencing; Host-Parasite Interactions; Humans; Malaria, Falciparum; Mitosis; Multidrug Resistance-Associated Proteins; Plasmodium falciparum | 2013 |
Quinolone-3-diarylethers: a new class of antimalarial drug.
Topics: Animals; Antimalarials; Atovaquone; Drug Resistance; Drug Synergism; Life Cycle Stages; Malaria; Malaria, Falciparum; Mice; Plasmodium falciparum; Plasmodium vivax; Proguanil; Pyridones; Quinolones | 2013 |
New options for the prevention and treatment of malaria: focus on the role of atovaquone and proguanil hydrochloride.
Topics: Atovaquone; Chemoprevention; Dose-Response Relationship, Drug; Drug Combinations; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Travel | 1999 |
[Treatment of severe and uncomplicated falciparum malaria in children in France].
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Ethanolamines; Fluorenes; France; Humans; Malaria, Falciparum; Proguanil; Quinolines | 2013 |
Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country.
Topics: Antimalarials; Artemisinins; Atovaquone; Burkina Faso; Disease Progression; Drug Combinations; Endemic Diseases; Humans; Lactones; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Proguanil; Time Factors; Travel | 2013 |
Autochthonous falciparum malaria possibly transmitted by luggage-carried vector in Paris, France, February 2013.
Topics: Animals; Atovaquone; Drug Combinations; Humans; Malaria, Falciparum; Male; Paris; Plasmodium falciparum; Proguanil; Travel; Treatment Outcome | 2013 |
Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Child; Drug Combinations; Female; France; Humans; Malaria, Falciparum; Male; Middle Aged; Proguanil; Transients and Migrants; Travel; Treatment Outcome; Young Adult | 2013 |
Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report.
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Magnetic Resonance Imaging; Malaria, Falciparum; Male; Myocarditis; Plasmodium falciparum; Proguanil; Troponin T; Young Adult | 2014 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.
Topics: Adolescent; Antimalarials; Atovaquone; Child; DNA, Mitochondrial; Drug Combinations; Drug Resistance; Erythrocytes; Female; Genome, Mitochondrial; Humans; Infant; Life Cycle Stages; Malaria, Falciparum; Male; Middle Aged; Mitochondria; Models, Statistical; Mutation; Plasmodium falciparum; Proguanil; Treatment Failure; Young Adult | 2014 |
"Collateral" effect of artemether in an atypical kidney involvement by Plasmodium falciparum malaria: a case report.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Artemether; Artemisinins; Atovaquone; Body Temperature; Cote d'Ivoire; Creatinine; Cyclophosphamide; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Immunosuppression Therapy; Kidney; Malaria, Falciparum; Methylprednisolone; Proguanil; Proteinuria; Treatment Outcome | 2014 |
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment.
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Resistance; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Proguanil | 2014 |
Understanding the mechanism of atovaquone drug resistance in Plasmodium falciparum cytochrome b mutation Y268S using computational methods.
Topics: Antimalarials; Atovaquone; Computer Simulation; Cytochromes b; Drug Resistance; Malaria, Falciparum; Mutation; Plasmodium falciparum | 2014 |
Artemether-lumefantrine compared to atovaquone-proguanil as a treatment for uncomplicated Plasmodium falciparum malaria in travelers.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Proguanil; Travel | 2015 |
An imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Azithromycin; Babesiosis; Benin; Blood; Coinfection; Drug Combinations; France; Humans; Korea; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Proguanil; Travel; Treatment Outcome | 2014 |
Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.
Topics: Alleles; Antimalarials; Atovaquone; Codon; Cytochromes b; DNA, Protozoan; Drug Combinations; Kenya; Malaria, Falciparum; Microbial Sensitivity Tests; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Proguanil; Protozoan Proteins | 2015 |
Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite.
Topics: Animals; Antimalarials; Atovaquone; Breast Neoplasms; Caenorhabditis elegans; Cell Line; Cell Line, Tumor; Female; Fibroblasts; Fungi; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Metabolic Detoxication, Phase I; Proguanil | 2016 |
Plasmodium falciparum malaria occurring four years after leaving an endemic area.
Topics: Antimalarials; Atovaquone; Disease Transmission, Infectious; Drug Combinations; Endemic Diseases; Female; Ghana; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Proguanil; Recurrence; Travel | 2016 |
Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro.
Topics: Adult; Antimalarials; Atovaquone; Cell Survival; Cytogenetics; DNA Damage; Dose-Response Relationship, Drug; Drug Combinations; Glutathione; Humans; Lymphocytes; Malaria, Falciparum; Male; Malondialdehyde; Oxidative Stress; Plasmodium falciparum; Proguanil; Triazines | 2015 |
39-Year-Old Woman With Headache and Fever.
Topics: Adult; Antimalarials; Atovaquone; Carotid Artery Diseases; Carotid Artery, Internal; Chemoprevention; Cote d'Ivoire; Diagnosis, Differential; Drug Combinations; Female; Fever; Headache; Humans; Intracranial Aneurysm; Magnetic Resonance Imaging; Malaria, Falciparum; Neurosurgical Procedures; Plasmodium falciparum; Proguanil; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.
Topics: Antimalarials; Artemisinins; Atovaquone; Base Sequence; Cambodia; DNA, Protozoan; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Quinolines; Sequence Analysis, DNA; Thailand | 2015 |
Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them.
Topics: Amodiaquine; Antimalarials; Artemisinins; Atovaquone; Female; Humans; Malaria, Falciparum; Male; Proguanil | 2016 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
Topics: Antimalarials; Atovaquone; Drug Combinations; Hepatocytes; Humans; Inhibitory Concentration 50; Liver; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Triazines | 2016 |
Advanced Molecular Detection of Malarone Resistance.
Topics: Adult; Antimalarials; Atovaquone; Cytochromes b; Drug Combinations; Drug Resistance; Gene Expression; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Male; Mutation; Nigeria; Plasmodium falciparum; Proguanil; Protozoan Proteins; Travel; Treatment Failure; United States | 2016 |
Characterization of a Plasmodium falciparum Orthologue of the Yeast Ubiquinone-Binding Protein, Coq10p.
Topics: Atovaquone; Carrier Proteins; Gene Expression Regulation; Humans; Malaria, Falciparum; Mitochondria; Plasmodium falciparum; Respiration; Saccharomyces cerevisiae; Ubiquinone | 2016 |
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Topics: Adult; Analysis of Variance; Animals; Antigens, Protozoan; Antimalarials; Atovaquone; Biomarkers; C-Reactive Protein; Calcitonin; Drug Combinations; Female; France; Host-Parasite Interactions; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Proguanil; Prospective Studies; Protozoan Proteins; Quinine; Severity of Illness Index | 2016 |
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Topics: Animals; Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Electron Transport Complex III; Female; Malaria, Falciparum; Mice; Parasitemia; Plasmodium falciparum; Proguanil; Quinolones | 2016 |
[Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child].
Topics: Antimalarials; Atovaquone; Child, Preschool; Communicable Diseases, Imported; Cote d'Ivoire; Drug Combinations; Drug Resistance, Multiple; Female; France; Humans; Malaria, Falciparum; Mali; Proguanil; Travel-Related Illness | 2017 |
Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Computational Biology; Drug Combinations; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Emetine; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil | 2017 |
The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Epidemiological Monitoring; Genotyping Techniques; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Reagent Kits, Diagnostic; Sulfadoxine | 2017 |
Bullous erythema multiforme after treatment with Malarone, a combination antimalarial composed of atovaquone and proguanil hydrochloride.
Topics: Antimalarials; Atovaquone; Drug Combinations; Erythema Multiforme; Female; Humans; Kenya; Malaria, Falciparum; Middle Aged; Proguanil | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Topics: Adult; Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Recurrence; Time Factors; Treatment Failure | 2008 |
Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.
Topics: Adult; Alleles; Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Haplotypes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; United Kingdom | 2009 |
Atovaquone + proguanil: new indication. For children weighing as little as 5 kg; an inconvenient form. A flavoured syrup would be better suited to infants and young children.
Topics: Administration, Oral; Antimalarials; Atovaquone; Body Weight; Chemistry, Pharmaceutical; Child; Child, Preschool; Dosage Forms; Drug Administration Schedule; Drug Approval; Drug Combinations; France; Humans; Infant; Malaria; Malaria, Falciparum; Proguanil; Tablets | 2009 |
Mefloquine has more adverse effects than other drugs for malaria prophylaxis.
Topics: Antimalarials; Atovaquone; Doxycycline; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Review Literature as Topic; Suicide | 2009 |
Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.
Topics: Antimalarials; Atovaquone; Chemoprevention; Doxycycline; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Proguanil; Retrospective Studies; Risk Factors; Travel; Treatment Outcome; United Kingdom | 2009 |
Rapid identification of chloroquine and atovaquone drug resistance in Plasmodium falciparum using high-resolution melt polymerase chain reaction.
Topics: Antimalarials; Atovaquone; Chloroquine; DNA, Protozoan; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Nucleic Acid Denaturation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sensitivity and Specificity | 2010 |
Letter to the editor of travel medicine and infectious disease.
Topics: Antimalarials; Atovaquone; Chemoprevention; Doxycycline; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Travel Medicine | 2010 |
Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Child; Cytochromes b; Drug Combinations; Drug Resistance; Ethanolamines; Ethiopia; Female; Fluorenes; Genotype; Hospitals, University; Humans; Malaria, Falciparum; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prevalence; Proguanil; Quinine; Recurrence; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase; Young Adult | 2010 |
[Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Topics: Antimalarials; Atovaquone; Cerebrospinal Fluid; Cognition Disorders; Confusion; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Hepatitis; Humans; Lymphocyte Count; Malaria, Cerebral; Malaria, Falciparum; Male; Meningitis, Aseptic; Middle Aged; Parasitemia; Proguanil; Recurrence; Syndrome | 2011 |
Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection.
Topics: Atovaquone; Dihydroorotate Dehydrogenase; Drug Resistance; Gene Silencing; Genetic Vectors; Humans; Malaria, Falciparum; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium falciparum; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transfection | 2011 |
Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages.
Topics: Antimalarials; Atovaquone; Chloroquine; Erythrocytes; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Triterpenes | 2011 |
[Atovaquone-proguanil treatment failure in Plasmodium falciparum].
Topics: Adult; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Emigrants and Immigrants; France; Guinea; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Proguanil; Quinine; Recurrence; Travel; Treatment Failure | 2011 |
Malaria therapy in HIV: drug interactions between nevirapine and quinine.
Topics: Anti-HIV Agents; Antimalarials; Atovaquone; Drug Combinations; Drug Interactions; HIV Infections; Humans; Malaria, Falciparum; Male; Middle Aged; Nevirapine; Nigeria; Proguanil; Quinine; Travel; United Kingdom | 2011 |
Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
Topics: Adult; Antimalarials; Atovaquone; Child, Preschool; Drug Combinations; Female; Humans; Infant; Japan; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Proguanil; Treatment Outcome | 2012 |
Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.
Topics: Antimalarials; Atovaquone; Cote d'Ivoire; Cytochromes b; Drug Combinations; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Proguanil; Treatment Failure | 2012 |
Erythema multiforme and Malarone(®).
Topics: Aged; Antimalarials; Atovaquone; Diagnosis, Differential; Drug Combinations; Erythema Multiforme; Female; Humans; Malaria, Falciparum; Proguanil | 2012 |
Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.
Topics: Artemisinins; Atovaquone; Base Sequence; Cambodia; Carrier State; Cross-Sectional Studies; Demography; Drug Combinations; Drug Resistance; Humans; Interviews as Topic; Malaria, Falciparum; Mass Screening; Molecular Sequence Data; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Primaquine; Proguanil; Sequence Analysis, DNA; Statistics, Nonparametric | 2012 |
Incidence of malaria among mosquito collectors conducting human landing catches in western Kenya.
Topics: Adolescent; Adult; Atovaquone; Cohort Studies; Drug Combinations; Humans; Incidence; Kenya; Logistic Models; Malaria, Falciparum; Male; Middle Aged; Proguanil; Prospective Studies; Risk Factors; Surveys and Questionnaires; Young Adult | 2013 |
[Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria--report of 112 cases].
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Drug Therapy, Combination; Female; Gastritis; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Proguanil; Recurrence; Retrospective Studies; Treatment Outcome | 2002 |
Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Female; Humans; Insect Vectors; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil; Serum Bactericidal Test | 2003 |
Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
Topics: Antimalarials; Antiprotozoal Agents; Atovaquone; Child, Preschool; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Naphthoquinones; Proguanil; Tablets | 2003 |
Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Atovaquone; Codon; Drug Resistance; Electron Transport Complex III; Genetic Markers; Humans; Malaria, Falciparum; Mutation; Naphthoquinones; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proguanil; Triazines | 2003 |
Problems in prescribing malaria chemoprophylaxis for travelers.
Topics: Animals; Antimalarials; Atovaquone; Child; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Immunocompromised Host; Insect Bites and Stings; Malaria, Falciparum; Mosquito Control; Naphthoquinones; Patient Compliance; Pregnancy; Proguanil; Travel | 2003 |
Plasmodium falciparum outwits Malarone, protector of travellers.
Topics: Animals; Antimalarials; Atovaquone; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Naphthoquinones; Plasmodium falciparum; Proguanil | 2003 |
Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Topics: Adult; Animals; Antimalarials; Atovaquone; Cytochrome b Group; Drug Resistance; Drug Therapy, Combination; Female; Humans; Kenya; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil; Travel; Treatment Failure | 2003 |
Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Cameroon; Child; Culture Media; DNA Primers; Drug Resistance; Electron Transport Complex III; Humans; Malaria, Falciparum; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Atovaquone/proguanil resistance in Africa: a case report.
Topics: Adult; Africa; Animals; Atovaquone; Bacterial Proteins; Cytochrome b Group; Denmark; Drug Resistance, Multiple; Drug Therapy, Combination; Ferritins; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Mutation; Naphthoquinones; Pharmacogenetics; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Risk Assessment; Travel; Treatment Failure | 2003 |
Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Topics: Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Folic Acid Antagonists; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Naphthoquinones; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Proguanil; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Triazines | 2004 |
Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
Topics: Adult; Animals; Antimalarials; Atovaquone; Biological Availability; Cytochromes b; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Point Mutation; Proguanil; Treatment Failure | 2004 |
Quinine-resistant severe falciparum malaria effectively treated with atovaquone and proguanil hydrochloride combination therapy.
Topics: Adult; Atovaquone; Blood Chemical Analysis; Bone Marrow Cells; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Naphthoquinones; Proguanil; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Codon; Cytochromes b; DNA, Protozoan; Drug Combinations; Drug Resistance; Europe; Female; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Middle Aged; Molecular Epidemiology; Mutation, Missense; Naphthoquinones; Plasmodium falciparum; Point Mutation; Polymorphism, Restriction Fragment Length; Proguanil; Protozoan Proteins; Treatment Failure | 2004 |
In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
Topics: Animals; Antimalarials; Atovaquone; Culture Media; Cytochrome b Group; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Recurrence; Triazines | 2005 |
Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
Topics: Adult; Animals; Antimalarials; Atovaquone; Canada; Cytochromes b; Drug Resistance; Female; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil; Sierra Leone | 2005 |
Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
Topics: Animals; Antimalarials; Atovaquone; Biological Assay; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Half-Life; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil | 2005 |
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Cytochromes b; Drug Resistance; Drug Synergism; Female; France; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Proguanil; Travel | 2006 |
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Half-Life; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Proguanil; Sesquiterpenes; Thailand | 2006 |
Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Topics: Angola; Animals; Antimalarials; Atovaquone; Cytochromes b; DNA Mutational Analysis; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Naphthoquinones; Plasmodium falciparum; Polymorphism, Genetic; Proguanil; Travel | 2006 |
[Malaria: a medical and economic problem].
Topics: Anti-Infective Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Naphthoquinones; Proguanil; Sesquiterpenes; Survival Rate; World Health Organization | 2006 |
Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
Topics: Africa; Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Cytochromes b; Drug Resistance; Emigration and Immigration; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction | 2006 |
Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.
Topics: Animals; Antimalarials; Apoptosis; Atovaquone; Cells, Cultured; Chloroquine; DNA Fragmentation; DNA, Protozoan; Enzyme Inhibitors; Erythrocytes; Etoposide; Flow Cytometry; Humans; In Situ Nick-End Labeling; Malaria, Falciparum; Membrane Potentials; Mitochondrial Membranes; Naphthoquinones; Nitric Oxide Donors; Parasitemia; Penicillamine; Plasmodium falciparum | 2006 |
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Topics: Adolescent; Adult; Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Codon; Cytochromes b; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil | 2006 |
Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Child; Codon; Cytochromes b; DNA, Protozoan; Drug Resistance; Humans; Malaria, Falciparum; Malawi; Molecular Sequence Data; Mutation, Missense; Naphthoquinones; Nigeria; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Proguanil; Protozoan Proteins; Senegal; Sequence Alignment; Sequence Homology, Amino Acid; Travel | 2006 |
Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.
Topics: Adult; Antimalarials; Atovaquone; Child, Preschool; Female; Humans; Immunocompetence; Infant; Japan; Malaria, Falciparum; Male; Mefloquine; Proguanil | 2006 |
Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
Topics: Adult; Animals; Antimalarials; Atovaquone; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pregnancy; Proguanil; Randomized Controlled Trials as Topic; Travel | 2007 |
Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
Topics: Animals; Antimalarials; Atovaquone; Cytochromes b; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Thailand; Travel | 2007 |
First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Topics: Animals; Antimalarials; Atovaquone; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; South America | 2007 |
Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.
Topics: Animals; Antimalarials; Atovaquone; Base Sequence; Biological Evolution; Cytochromes b; DNA Mutational Analysis; DNA, Mitochondrial; Drug Resistance; Humans; Malaria, Falciparum; Molecular Sequence Data; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Sequence Homology, Nucleic Acid | 2007 |
Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees.
Topics: Adolescent; Ambulatory Care; Antimalarials; Atovaquone; Australia; Child; Child, Preschool; Female; Follow-Up Studies; Hospitalization; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Proguanil; Quinine; Refugees | 2007 |
A man with tropical travel history, fever, and pulmonary infiltrates.
Topics: Africa, Western; Aged; Animals; Antimalarials; Atovaquone; Doxycycline; Drug Combinations; Fever; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Proguanil; Quinidine; Quinine; Respiratory Distress Syndrome; Travel; Tropical Climate | 2007 |
Synergistic interaction between atovaquone and retinol in Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lethal Dose 50; Malaria, Falciparum; Plasmodium falciparum; Survival Rate; Treatment Outcome; Vitamin A | 2007 |
Synergistic interaction between monodesbutyl-benflumetol and retinol in Plasmodium falciparum.
Topics: Animals; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lethal Dose 50; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Survival Rate; Treatment Outcome; Vitamin A | 2007 |
In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Topics: Animals; Antimalarials; Atovaquone; Codon; Cytochromes b; Drug Resistance, Multiple; Genes, Protozoan; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymorphism, Restriction Fragment Length; Proguanil; Protozoan Proteins; Thailand | 2008 |
Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.
Topics: Adult; Animals; Antimalarials; Atovaquone; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Proguanil; Treatment Failure | 2008 |
[Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
Topics: Animals; Antimalarials; Atovaquone; C-Reactive Protein; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Hospitals, University; Humans; Liver Function Tests; Malaria, Falciparum; Paris; Plasmodium falciparum; Proguanil; Retrospective Studies; Travel | 2008 |
Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
Topics: Animals; Antimalarials; Atovaquone; Child; Cytochromes c; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Mozambique; Mutation, Missense; North America; Parasitemia; Plasmodium falciparum; Proguanil; Treatment Failure | 2008 |
PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Atovaquone; Drug Synergism; Folic Acid Antagonists; Imides; Injections, Subcutaneous; Malaria, Falciparum; Mice; Naphthoquinones; Phenyl Ethers; Plasmodium falciparum; Proguanil; Sulfamethoxazole; Triazines | 1993 |
Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Atovaquone; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones | 1996 |
Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
Topics: Animals; Antimalarials; Atovaquone; Biological Assay; Dapsone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Regression Analysis; Saimiri; Sulfamethoxazole | 1997 |
Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
Topics: Animals; Antimalarials; Atovaquone; Dapsone; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Plasmodium falciparum; Proguanil; Thailand | 1997 |
Malarone-donation programme in Africa.
Topics: Africa; Altruism; Antimalarials; Atovaquone; Developing Countries; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil | 1998 |
Malaria prophylaxis for the 1990s and beyond.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Proguanil | 1997 |
Antimalarial drug resistance and combination chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Sesquiterpenes | 1999 |
Atovaquone-proguanil for falciparum malaria in the Philippines.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Philippines; Proguanil; Pyrimethamine; Sulfadoxine | 2000 |
Atovaquone/Proguanil (Malarone) for malaria.
Topics: Abdominal Pain; Administration, Oral; Antimalarials; Atovaquone; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Fees, Pharmaceutical; Humans; Malaria, Falciparum; Naphthoquinones; Nausea; Proguanil | 2000 |
Prophylactic effect of Malarone against malaria: all good news?
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Travel; Treatment Outcome | 2000 |
A political analysis of corporate drug donations: the example of Malarone in Kenya.
Topics: Antimalarials; Atovaquone; Communicable Disease Control; Drug Combinations; Drug Industry; Financing, Organized; Humans; Interinstitutional Relations; Kenya; Malaria, Falciparum; Naphthoquinones; Policy Making; Politics; Private Sector; Program Evaluation; Proguanil; Public Sector | 2001 |
Malaria remains a military medical problem.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Global Health; Humans; Kenya; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Medicine; Military Personnel; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Sierra Leone; Treatment Failure; Treatment Outcome; United Kingdom | 2001 |
Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Atovaquone; Computer Simulation; Drug Resistance; Humans; Malaria, Falciparum; Models, Biological; Mutation; Naphthoquinones; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Time Factors | 2001 |
[Malarone: a new antimalarial for malaria chemoprevention].
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil | 2002 |
Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
Topics: Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Codon; Cytochromes b; Drug Combinations; Drug Resistance; Humans; London; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Naphthoquinones; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Travel | 2002 |
566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Infective Agents; Antimalarials; Aotus trivirgatus; Atovaquone; Dogs; Humans; Malaria, Falciparum; Male; Microsomes, Liver; Middle Aged; NADP; Naphthoquinones; Opportunistic Infections; Plasmodium; Rats; Toxoplasma | 1991 |